Status:
COMPLETED
The Prevalence and Characteristics of Adrenal Incidentaloma
Lead Sponsor:
Chongqing Medical University
Conditions:
Prevalence
Adrenal Incidentaloma
Eligibility:
All Genders
18-78 years
Brief Summary
To investige the prevalence, characteristics and prognosis of adrenal incidentalomas in Chinese adults.
Detailed Description
With the development of imaging detection technology and its wide application in clinic, the detection rate of adrenal incidentaloma (AI) has been greatly improved. Most AI are benign and do not have ...
Eligibility Criteria
Inclusion
- ·On weekdays, the first 100 individuals, aged 18 to 78 years, taking health checkup in the Community Health Examination Center were invited to take part in the study.
Exclusion
- with known adrenal diseases;
- with continuous steroids or drug treatment that might influence cortisol secretion ordexamethasone metabolism and could not be stopped
- refuse to participate in the study.
Key Trial Info
Start Date :
November 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
25356 Patients enrolled
Trial Details
Trial ID
NCT04682938
Start Date
November 20 2020
End Date
November 30 2021
Last Update
August 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the First Affiliated Hospital of Chongqing Medical University, Chongqing, China
Chongqing, Chongqing Municipality, China, 400016